Macroscopic modeling of the singlet oxygen production during PDT

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6427, Issue , 2007, Pages

  Zhu, Timothy C ^a   Finlay, Jarod C ^a   Zhou, Xiaodong ^a   Li, Jun ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Oxygen dependence of singlet oxygen quantum yield; Photodynamic therapy; Singlet oxygen production

Indexed keywords

APPROXIMATION THEORY; CELL DEATH; CHARACTERIZATION; DIFFUSION; OXYGEN SUPPLY; OXYGENATION; PHOTOSENSITIZERS; TISSUE;

TISSUE ACCEPTORS; TURBID MEDIUM;

PHOTODYNAMIC THERAPY;

EID: 34548242280     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.701387     Document Type: Conference Paper

References (22)

1. T. J. Dougherty, D. J. Gomer, B. W. Henderson, and e. al., "Photodynamic Therapy," J. Natl. Cancer Inst. 90, 889-905 (1998).
2. T. C. Zhu, and J. C. Finlay, "Prostate PDT dosimetry," Photodiagnosis and Photodynamic Therapy 4, 234-246 (2006).
3. M. S. Patterson, B. C. Wilson, and R. Graff, " In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine," Photochem Photobiol 51, 343-349 (1990).
4. F. W. Hetzel, S. Brahmavar, Q. Chen, S. Jacques, M. S. Patterson, B. C. Wilson, and T. C. Zhu, AAPM Photodynamic Therapy Dosimetry, Report 88, (Med Phys Publishing, city, 2005).
5. C. S. Foote, "Photosenstizied oxidations and the role of singlet oxygen," Accounts Chem. Res. 1, 104-110 (1967).
6. M. Ochsner, "Photophysical and photobiological processes in the photodynamic therapy of tumours," J Photochem Photobiol B 39, 1-18(1997).
7. B. C. Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetry in photodynamic therapy: A new paradigm," Lasers Med. Sci. 12, 182-199 (1997).
8. M. J. Niedre, M. S. Patterson, A. Giles, and B. C. Wilson, "Imaging of Photodynamically Generated Singlet Oxygen Luminescence In Vivo," Photochem Photobiol, (2005).
9. M. Niedre, M. S. Patterson, and B. C. Wilson, "Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo," Photochem Photobiol 75, 382-91 (2002).
10. T. H. Foster, R. S. Murant, R. G. Bryant, R. S. Knox, S. L. Gibson, and R. Hilf, "Oxygen consumption and diffusion effects in photodynamic therapy," Radiat. Res. 126, 296-303 (1991).
11. X. H. Hu, Y. Feng, J. Q. Lu, R. R. Allison, R. E. Cuenca, G. H. Downie, and C. H. Sibata, "Modeling of a Type II Photofrin-mediated Photodynamic Therapy Process in a Heterogeneous Tissue Phantom," Photochem. Photobiol. 81, 1460-1468 (2005).
12. J. C. Finlay, S. Mitra, and T. H. Foster, "Photobleaching kinetics of Photofrin in vivo and in multicell tumor spheroids indicate multiple simultaneous bleaching mechanisms," Phys. Med. Biol. 49, 4837-4860 (2004).
13. S. Mitra, and T. H. Foster, "Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin," Photochem. Photobiol. 81, 849-59 (2005).
14. H. W. Wang, T. C. Zhu, M. E. Putt, M. Solonenko, J. Metz, A. Dimofte, J. Miles, D. L. Fraker, E. Glatstein, S. M. Hahn, and A. G. Yodh, "In-vivo broadband reflectance measurements of light penetration depth, blood oxygenation, hemoglobin concentration, and drug concentration in human tissues before and after photodynamic therapy," J Biomed Opt 10, (2005).
15. A. V. Hill, "The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves," J. Physiol. (Proc.) 40, iv-vii (1910).
16. J. P. Whiteley, D. J. Gavaghan, and C. E. Hahn, "Mathematical modelling of oxygen transport to tissue," J Math Biol 44, 503-22 (2002).
17. A. S. Popel, "Theory of oxygen transport to tissue," Crit Rev Biomed Eng 17, 257-321 (1989).
18. T. W. Secomb, R. Hsu, N. B. Beamer, and B. M. Coull, "Theoretical simulation of oxygen transport to brain by networks of microvessels: effects on tumor oxygen supply and demand on tissue hypoxia," Microcirculation 7, 237-47 (2000).
19. B. D. Kavanagh, T. W. Secomb, R. Hsu, P. S. Lin, J. Venitz, and M. W. Dewhirst, "A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation," Int J Radiat Oncol Biol Phys 53, 172-9 (2002).
20. B. J. McGuire, and T. W. Secomb, "A theoretical model for oxygen transport in skeletal muscle under conditions of high oxygen demand," J. Appl Physiol 91, 2255-65 (2001).
21. B. W. Pogue, K. D. Paulsen, J. A. O'Hara, C. M. Wilmot, and H. M. Swartz, "Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements," Radiât. Res. 155, 15-25 (2001).
22. T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. M. Busch, J. Miles, R. Whittington, S. B. Malkowicz, Z. Tochner, E. Glatstein, and S. M. Hahn, "Optical properties of Human Prostate at 732nm measured in vivo during Motexafin Lutetium-mediated photodynamic therapy," Photochem Photobiol 81, 96-105 (2005).